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Populations of neurons in the hypothalamic preoptic area (POA) fire rapidly during sleep,
exhibiting sleep/waking state-dependent firing patterns that are the reciprocal of those
observed in the arousal system. The majority of these preoptic “sleep-active” neurons
contain the inhibitory neurotransmitter GABA. On the other hand, a population of neurons
in the lateral hypothalamic area (LHA) contains orexins, which play an important role in
the maintenance of wakefulness, and exhibit an excitatory influence on arousal-related
neurons. It is important to know the anatomical and functional interactions between the
POA sleep-active neurons and orexin neurons, both of which play important, but opposite
roles in regulation of sleep/wakefulness states. In this study, we confirmed that specific
pharmacogenetic stimulation of GABAergic neurons in the POA leads to an increase in the
amount of non-rapid eye movement (NREM) sleep. We next examined direct connectivity
between POA GABAergic neurons and orexin neurons using channelrhodopsin 2 (ChR2) as
an anterograde tracer as well as an optogenetic tool. We expressed ChR2-eYFP selectively
in GABAergic neurons in the POA by AAV-mediated gene transfer, and examined the
projection sites of ChR2-eYFP-expressing axons, and the effect of optogenetic stimulation
of ChR2-eYFP on the activity of orexin neurons. We found that these neurons send
widespread projections to wakefulness-related areas in the hypothalamus and brain
stem, including the LHA where these fibers make close appositions to orexin neurons.
Optogenetic stimulation of these fibers resulted in rapid inhibition of orexin neurons.
These observations suggest direct connectivity between POA GABAergic neurons and
orexin neurons.
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INTRODUCTION
The preoptic area (POA) of the hypothalamus has been impli-
cated in a variety of physiological functions, including the regu-
lation of sleep/wakefulness states (Boulant, 1981; McGinty et al.,
2001). Especially, this region is thought to play an important role
in the initiation and maintenance of sleep. Initially, electrical or
chemical stimulation of the lateral POA in animals was shown to
promote EEG slow-wave activity and sleep onset (Sterman and
Clemente, 1962; Benedek et al., 1982; Ticho and Radulovacki,
1991; Mendelson and Martin, 1992). Consistently, lesions in the
POA have been shown to result in profound and persistent sleep
loss (John and Kumar, 1998; Lu et al., 2000). However, these stud-
ies are not genetically targeted to specific neuron types, and so the
cells that are responsible remain to be clarified. In this study, we
focused on the GABAergic neurons, as some of them have been
shown to provide inputs in particular to the arousal system. We
examined the role of the projection from GABAergic neurons in
the POA to the orexin neurons in the LHA in inhibiting the latter
cells, and the effect of activating this pathway on sleep.
Extracellular recording studies have identified sleep-active
neurons in a region extending from the medial through the lat-
eral POA (Kaitin, 1984; Koyama and Hayaishi, 1994), while it
was reported that neurons in the rat ventrolateral preoptic area
(VLPO) and median preoptic nucleus (MnPN) exhibited Fos
expression following consolidated sleep (Gong et al., 2000). The
POA was shown to send GABAergic inhibitory projections to
monoaminergic regions, including the locus coeruleus (LC), dor-
sal raphe nucleus (DRN), and tuberomammilary nucleus (TMN)
(Sherin et al., 1996, 1998; Steininger et al., 2001; Uschakov et al.,
2007). Consistently, firing patterns of monoaminergic neurons in
these nuclei across the sleep-waking cycle are the reciprocal of
those observed in POA sleep-active neurons. They fire at a rapid
rate during wakefulness, slow down during non-rapid eye move-
ment (NREM) sleep, and cease firing during rapid eye movement
(REM) sleep (Saper et al., 2001). Electrophysiological studies sug-
gested that VLPO neurons are inhibited by noradrenaline and
serotonin (Gallopin et al., 2000), suggesting mutually inhibitory
interactions between VLPO and the monoaminergic arousal sys-
tems (Saper et al., 2001).
Monoaminergic arousal systems are also thought to be regu-
lated by orexin neuropeptides, which are thought to be a critical
regulator of sleep/wake states (Sakurai, 2007). Orexin deficiency
causes the sleep disorder narcolepsy in humans and animals
(Chemelli et al., 1999; Lin et al., 1999; Peyron et al., 2000;
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Thannickal et al., 2000; Hara et al., 2001). Orexin-producing neu-
rons (orexin neurons) in the lateral hypothalamic area (LHA)
send dense axonal projections to monoaminergic neurons in the
brain stem/hypothalamic regions. Recent studies have suggested
the POA also sends projections to orexin neurons in the LHA
(Sakurai et al., 2005; Yoshida et al., 2006). However, how the
endogenous firing of POA sleep-active neurons affects the activity
of orexin neurons has been unknown. Functional studies of this
issue are important, because both POA sleep active neurons and
orexin neurons play highly important roles in the physiological
regulation of sleep.
To examine the electrophysiological impact of activity of
endogenous POA neurons, we first confirmed that selective phar-
macogenetic stimulation of GABAergic neurons in the POA,
using the Designer Receptors Exclusively Activated by Designer
Drugs (DREADD) technology, leads to an increase of NREM
sleep (Armbruster et al., 2007). We also used channelrhodopsin-
2 (ChR2) as an anterograde tracer as well as an optogenetic
tool (Bernstein et al., 2012; Yizhar et al., 2011) for selective
optical excitation of GABAergic POA neurons and their axons.
We examined the axonal projections of ChR2-eYFP-positive
fibers and confirmed that POA GABAergic neurons send abun-
dant projections to arousal-related regions, including the LC,
DR, TMN, and laterodorsal/pedunculopontine tegmental nucleui
(LDT/PPT). Dense projections were also found in the LHA,
and these GABAergic fibers made appositions to orexin neurons.
We then explored the effects of fast and selective optogenetic
stimulation of GABAergic axons on orexin neurons. By com-
bining whole-cell patch-clamp recordings from orexin neurons
with optogenetic stimulation of GABAergic axons in acute mouse
brain slices, we found that photostimulation of POA GABAergic
fibers immediately caused a decrease in the firing rate of orexin
neurons through GABA release. These observations suggest that
POA GABAergic neurons send direct inhibitory projections to
orexin neurons.
MATERIALS AND METHODS
ANIMALS
All experimental procedures involving animals were approved
by the Animal Experiment and Use Committee of Kanazawa
University (AP-132649), and were thus in accordance with NIH
guidelines. Gad67-Cre mice, in which the Cre gene was knocked-
in in the Gad67 allele were previously described (Wu et al., 2011).
The mice were bred with wild type C57BL/6J mice more than ten
times and maintained.
AAV PRODUCTION AND PURIFICATION
We used AAV with the FLEX switch system (Atasoy et al., 2008) to
specifically express HA-tagged hM3Dq or ChR2 fused with EYFP
(ChR2-EYFP) only in Cre recombinase-expressing neurons. We
applied this method to heterozygous Gad67-Cre mice in which
the Cre recombinase gene is specifically expressed in GABAergic
neurons (Wu et al., 2011).
pAAV-DIO-HAhM3Dqwas provided by Dr. Brian Roth. pAAV-
DIO-hChR2(H134R)-EYFP-WPRE-pA was provided by Dr. Karl
Deisseroth of Stanford University (Kozorovitskiy et al., 2012).
We constructed a plasmid, pAAV-horexin-tdTomato-WPRE-pA, as
follows. A 1.3-kb fragment of the human prepro-orexin gene pro-
moter, which has the ability to drive expression in orexin neurons
specifically (Moriguchi et al., 2002), was amplified by PCR with
a pair of primers 5′-CACGCGTGCATGCTGTAATCCCAGCTAC-
3′ and 5′-TGTCGACGGTGTCTGGCGCTCAGGGTG-3′. The
PCR product was fully sequenced and digested by MluI
and SalI, and ligated to Mlu I and SalI-digested pAAV-
DIO-hChR2(H134R)-EYFP-WPRE-pA, yielding pAAV-horexin-
hChR2(H134R)-EYFP-WPRE-pA. The tdTomato gene fragment
from ptdTomato (Clontech) was inserted into the EcoRI and SalI
sites of pAAV-horexin-hChR2(H134R)-EYFP-WPRE-pA, yielding
pAAV-horexin-tdTomato-WPRE-pA.
Viruses were produced using a triple-transfection, helper-free
method using a modification of a published protocol (Auricchio
et al., 2001; Sasaki et al., 2011). The final purified viruses
were aliquoted and stored at −80◦C. The titers of AAV-DIO-
hChR2(H134R)-EYFP and AAV-orexin-tdTomato were 1.63 ×
1012 and 1.03 × 1012 genome copies/ml, respectively.
VIRUS INJECTION
Adenoassociated-virus AAV-DIO-HAhM3Dq or AAV-DIO-
hChR2(H134R)-EYFP was injected into the POA of Gad67-Cre
mice (Wu et al., 2011). In in vitro electrophysiological exper-
iments for recording orexin neurons, AAV-orexin-tdTomato
was simultaneously injected into the LHA of these mice for
identification of orexin neurons (Figure 4A). Male mice were
anesthetized with isofluorane and placed in a stereotaxic frame
(David Kopf Instruments). For injection into the POA, two holes
were drilled into the skull of Gad67-Cre mice (12–15 weeks
of age, weight 25–30 g), at sites +0.3mm anterior, ±0.65mm
lateral, and −5.72mm ventral to the bregma under deep anes-
thesia. For injection into the LHA, four holes were drilled into
the skull of each mouse under anesthesia, at sites −1.4mm
posterior, ±0.9mm lateral, and −5.5mm ventral; and −1.8mm
posterior, ±0.9mm lateral, and −5.7mm ventral to the bregma
(four injection sites per mouse).
A Hamilton needle syringe (33-gauge) was placed at each site,
and 0.5µl purified virus was delivered to each site over a 10-min
period. After 5min of rest, the needles were removed. The mice
were sacrificed 14 days later, and slice preparations were ana-
lyzed by electrophysiological experiments and tissue samples by
immunohistochemical staining.
ELECTROPHYSIOLOGY
Acute slices containing the LHA were prepared from the mice
14 days post-AAV injection, as described in our previous stud-
ies (Tsujino et al., 2005). The mice were decapitated under deep
anesthesia. Brains were isolated in ice-cold cutting solution con-
sisting of (mM): 280 sucrose, 2 KCl, 10 HEPES, 0.5 CaCl2,
10 MgCl2, 10 glucose, pH 7.4, bubbled with 100% O2. Brains
were cut coronally into 300-µm slices with a vibratome (VTA-
1200S, Leica, Germany). Slices were transferred to an incubation
chamber at room temperature filled with physiological solu-
tion containing (mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2.0
CaCl2, 1.0 MgSO4, 26 NaHCO3, 11 glucose, pH 7.4, bubbled with
95% O2/5% CO2. After 1-h incubation in an incubation cham-
ber, the slices were transferred to a recording chamber (RC-27L,
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Warner Instrument Corp., CT, USA) at 32◦C on a fluorescence
microscope stage (BX51WI, Olympus, Tokyo, Japan). Neurons
that showed tdTomato fluorescence were used for patch-clamp
recordings. The fluorescence microscope was equipped with an
infrared camera (C-3077, Hamamatsu Photonics, Hamamatsu,
Japan) for infrared differential interference contrast (IR-DIC)
imaging and a CCD camera (JK-TU53H, Olympus) for fluores-
cent imaging. Each image was displayed separately on a monitor.
Recordings were carried out with an Axopatch 200B amplifier
(Axon Instruments, Foster City, CA) using a borosilicate pipette
(GC150-10, Harvard Apparatus, Holliston, MA) prepared using
a micropipette puller (P-97, Sutter Instruments, Pangbourne,
UK) and filled with intracellular solution (4–10M), consist-
ing of (mM): 125K-gluconate, 5 KCl, 1 MgCl2, 10 HEPES, 1.1
EGTA-Na3, 5 MgATP, 0.5 Na2GTP, pH7.3 with KOH. Osmolarity
of the solution was checked with a vapor pressure osmometer
(model 5520, Wescor, Logan, UT). The osmolarity of the inter-
nal and external solutions was 280–290 and 320–330mOsm/l,
respectively. The liquid junction potential of the patch pipette
and perfused extracellular solution was estimated to be−16.2mV
and was applied to the data. The recording pipette was under
positive pressure while it was advanced toward individual cells
in the slice. Tight seals of 0.5–1.0G were made by applying
negative pressure. The membrane patch was then ruptured by
suction. The series resistance during recording was 10–25M
and was compensated. The reference electrode was an Ag-AgCl
pellet immersed in bath solution. During recordings, cells were
superfused with extracellular solution at a rate of 1.0–2.0ml/min
using a peristaltic pump (K.T. Lab, Japan).
Light activation was performed using an LED device (KSL-
70; Rapp OptoElectronic, Hamburg, Germany) at a wavelength
of 470 nm (maximum: 8mW/mm2). Pulse was generated with
SEN-3301 stimulator (Nihon Koden, Japan).
CLOZAPINE-N-OXIDE ADMINISTRATION
Clozapine N-oxide (CNO; C0832, Sigma-Aldrich) was dissolved
in saline to a concentration of 0.5mg/ml. Silicon tubes were
implanted for remote CNO injection. The tip of a 30 cm-long sil-
icon tube was inserted 1 cm into the peritoneal cavity and sutured
to the abdominal wall. The other end of the silicon tube was
placed outside the body through an incision in the neck, and all
incisions were sutured. All animals were then housed individually
for a recovery period of at least 7 days. CNO was administered to
each mouse (0.3ml/30 g body weight) through the silicon tube.
Injections were done at 21:00 and at 13:00.
SLEEP RECORDINGS
An electrode for EEG and EMG recording was implanted in the
skull of each mouse as decscribed previously (Hara et al., 2001).
The three arms of the electrode for EEG recording were placed
∼2mm anterior and 2mm to the right, 2mmposterior and 2mm
to the right, and 2mm posterior and 2mm to the left of the
bregma. Stainless steel wires for EMG recording were sutured to
the neckmuscles of eachmouse bilaterally, and each electrode was
glued solidly to the skull. After the recovery period, animals were
moved to a recording cage placed in an electrically shielded and
sound attenuated room. A cable for signal output was connected
to the implanted electrode and animals were allowed to move
freely. Signals were amplified through an amplifier (AB-611J,
Nihon Koden, Tokyo) and digitally recorded on a computer using
EEG/EMG recording software (Vital recorder, Kissei Comtec).
Animals were allowed at least 7 days to adapt to the recording
conditions prior to any EEG/EMG recording session. Following
the adaptation period, each animal was intraperitoneally admin-
istered both CNO and saline on separate experimental days with a
3-day interval. The order of injection was randomized. EEG/EMG
data were evaluated and staged for 3 h after administration. Data
acquired on the day of saline administration were used as con-
trol. We analyzed FFT spectra of NREM period in 1–2 h epoch of
saline- or CNO-injected mice (N = 14). Power spectral analysis
of EEG signals was performed using custom FFT software.
IMMUNOHISTOCHEMISTRY
To confirm GABAergic-specific expression of Cre recom-
binase activity in the POA of Gad67-Cre mice, we crossed
them with Rosa26-tdTomato tracer mice (B6; 129S6-
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J, Jackson Laboratory
#007905). Mice at 8 weeks of age were deeply anesthetized with
sodium pentobarbital and then fixed by intracardiac perfusion
with 4% paraformaldehyde. Then, the brain was post-fixed for
24 h in the same fixative and cryoprotected by immersion in
30% sucrose for 2 days. Cryostat sections (40-µm thick) of
the brains were incubated for 1 h in 0.1M phosphate buffer
containing 1% bovine serum albumin and 0.25% Triton-X-100,
and incubated overnight at 4◦C with rabbit anti-GAD65/67
antibody (Uchigashima et al., 2007) in the same solution. After
three washes in the same solution, the sections were incubated
with goat anti-rabbit IgG conjugated with Alexa 488 (Invitrogen,
Carlsbad, CA) for 90min at room temperature. After three
washes in 0.1M phosphate buffer, the sections were mounted
on glass slides and cover-slipped. Slides were examined with a
laser-confocal microscope (Olympus FV10i, Olympus, Japan).
To detect monoaminergic and cholinergic neurons, we used
mouse anti-tryptophan hydroxylase (TPH) antibody (Sigma,
T0648, 1:200), guinea pig anti-histidine decarboxylase (HDC)
antibody (PROGEN Biotechnik Gmbh, No.16046, 1:4,000),
rabbit anti-tyrosine hydroxylase (TH) antibody (Millipore,
AB152, 1:2,000), and goat anti-choline acetyltransferase (ChAT)
antibody (Millipore, Ab144D, 1:100). As a second antibody, Alexa
Fluor 594-goat anti-mouse IgG (Molecular Probes, 1:800), Alexa
Fluor 594-goat anti-guinea pig IgG (Molecular Probes, 1:800)
were used.
To detect Fos immunoreactivity in orexin-expressing neurons,
coronal sections were incubated overnight with rabbit anti-cFos
antibody Ab-5 (Calbiochem, 1:10000) and guenia pig anti-orexin
antibody in 0.1M phosphate buffer containing 1% bovine serum
albumin and 0.25% Triton X-100. The primary antibody was
localized with the avidin-biotin system (Vector). Bound peroxi-
dase was visualized by incubating sections with 0.01M imidazole
acetate buffer containing 0.05% hydrogen peroxide and 2.5%
nickel ammonium sulfate, resulting in a black reaction product
in the nuclei. The sections were then incubated with anti-guenia
pig IgG and then with the avidin-biotin-peroxidase complex
as described above. Nickel sulfate was omitted from the final
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incubation, resulting in a golden brown reaction product in the
cytoplasm. The numbers of cFos-positive and -negative orexin-
containing neurons were counted in coronal sections throughout
the hypothalamic region by a single examiner who was blinded to
the treatment conditions, using a Keyence BZ-9000 microscope
(Keyence, Japan). Cells were counted on both sides of the brain in
consecutive 40-µm sections. Orexin neuron activity was scored as
the percentage of double-labeled cells per animal.
In situ HYBRIDIZATION
Double in situ hybridization was performed according to proce-
dures previously described (Mieda et al., 2006). For double in
situ hybridization, each combination of two antisense riboprobes
labeled with either fluorescein-UTP (Gad1) or digoxygenin-UTP
(GFP) was hybridized to sections simultaneously. Following the
chromogenic reaction of the first color (blue) obtained with anti-
digoxygenin-alkaline phosphatase (AP) Fab fragments, 5-bromo-
4-chloro-3-indolyl phosphate (Roche) and nitroblue tetrazolium
(Roche), sections were rinsed three times with TBS, treated twice
with 0.1M glycine pH 2.2; 0.1% Tween 20 for 5min, washed, and
then incubated with anti-fluorescein-alkaline phosphatase (AP)
Fab fragments. For the chromogenic reaction of the second color
(orange), 5-bromo-4-chloro-3-indolyl phosphate (Roche) and
2-[4-iodophenyl]-3-[4-nitrophenyl]-5-phenyl-tetrazolium chlo-
ride (Roche) were used. Antisense riboprobes were synthesized
from plasmids containing GFP and mouse Gad1 (NM_008077,
nucleotides 281-821) cDNAs.
STATISTICAL ANALYSIS
Data were expressed as mean ± s.e.m. Two-way analysis of vari-
ance (ANOVA) followed by Bonfferoni correction as a post-hoc
test or Student’s t-test using IBM SPSS Statistics ver.19 was used
for comparison among the various treatment groups. Differences
were considered significant at p < 0.05.
RESULTS
PHARMACOGENETIC SELECTIVE STIMULATION OF POA GABAergic
NEURONS INCREASED NREM SLEEP
Before examining the connectivity between POA GABAergic
neurons and orexin neurons, we confirmed whether spe-
cific stimulation of GABAergic neurons in the POA affects
sleep/wakefulness states in mice. We applied the DREADD tech-
nology (Armbruster et al., 2007; Sasaki et al., 2011), to phamaco-
genetically manipulate the activity of POA GABAergic neurons.
To express hM3Dq in GABAergic neurons in the POA, we
injected AAV-DIO-HAhM3Dq into the POA of Gad67-Cre mice,
in which GABAergic neurons specifically express Cre recombi-
nase (Wu et al., 2011). GABAergic specific expression of Cre
recombinase in the POA of Gad67-Cre mice was confirmed
by crossing them with ROSA26-tdTomato mice (containing
tdTomato gene preceded by a transcriptional blocker flanked with
lox-P sites) (Figure 1A). We confirmed virtually all tdTomato-
expressing neurons were positive for Gad65/67 immunoreactivity
(95.4%). After injection of AAV-DIO-HAhM3Dq, we implanted
thin silicone tubes into the peritoneal space of Gad67-Cre
mice so that we could administer clozapine-N-oxide (CNO),
the synthetic ligand for hM3Dq, with minimal disturbance.
Fourteen days after virus injection, we administered CNO
to mice.
Fourteen days after the virus injection, we administered
CNO or saline intraperitoneally to Gad67-Cre mice expressing
hM3Dq at 13:00 (light period) or 21:00 (dark period). The
sleep/wakefulness states of these mice were monitored by simul-
taneous EEG/EMG recording. As a control, we treated the same
mice with saline on separate experimental days. Each mouse
was administered CNO or vehicle using a randomized crossover
design at an interval of 3 days.
After the recording, mice were subjected to immunostain-
ing with anti-HA antibody. We observed expression of HA-
immunoreactivity in the POA region of most mice (Figure 1B).
We injected the virus in 62 mice, and only used data obtained
from 14 mice in which the existence of HA-positive cell bodies
was limited within the POA. In many cases, we observed expres-
sion of HA-positive cells outside the POA, including the basal
forebrain regions, such as the horizontal nucleus of the diago-
nal band. Therefore, we gathered data from 14 mice, in which
HA-immunoreactivity was confined in the POA.
After the EEG/EMG recordings, we injected CNO (n = 8)
or saline (n = 6) into Gad67-Cre mice expressing hM3Dq at
21:00, sacrificed and fixed them at 23:00. Hypothalamic slices of
these mice were examined by double staining with anti-Fos and
anti-Gad65/67 antibodies to assess the activity of POA neurons
(Figure 1C).
We observed an approximately 2.5-fold increase in Fos-
positive GABAergic neurons in the whole POA of the CNO-
injected group as compared with the vehicle-injected group
(29.7 ± 3.7% vs. 76.6 ± 4.3%, p < 0.001) (Figure 1C). These
observations demonstrate that the DREADD system used in this
study appropriately stimulates the activity of POA neurons.
EEG/EMG analyses found that the percent of wakefulness
during 3 h after CNO administration was significantly shorter
(128.3 ± 3.3min vs. 112.7 ± 4.1min, p = 0.006), while NREM
time was longer in CNO-treated conditions than in saline-
injected control conditions in the dark period (49.9 ± 3.0min
vs. 65.1 ± 3.1min, p = 0.004) (Figure 2A). A significant increase
of NREM sleep was also observed for 3 h after administration
in the light period (13:00). We observed an increase in NREM
episode duration when CNOwas administered in the light period
(Figure 2B). Although we also observed similar tendency when
CNO was administered in the dark period, the difference was
not statistically significant. The power density of EEG of each
episode in the CNO-administered group in the dark period
showed no difference from that in the vehicle-administered group
(Figure 2C).
These results suggest that, consistent with previous non-
specific electrical and chemical stimulation studies of the POA,
specific stimulation of POA GABAergic neurons results in a
decrease of wakefulness time, accompanied by increased NREM
sleep time. We did not observe a significant difference in
REM sleep time between the CNO-injected and control groups
(Figure 2A).
We next examined the effect of stimulation of POA GABAergic
neurons on orexin neuronal activity by Fos-immunostaining.
After CNO or saline was injected at 21:00, the brains were fixed
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FIGURE 1 | Selective pharmacogenetic stimulation of POA neurons. (A)
Gad67-Cre mice were crossed with Rosa26-tdTomato reporter mice (see
method) to confirm GABAergic neuron-specific expression of Cre
recombinase. A representative image of the POA of the Gad67-Cre;
Rosa26-tdTomato mice is shown (Bregma-0.1mm). Left panels, upper,
tdTomato fluorescence. Lower, same section stained with Gad65/67
anti-body. Middle panel, merged image of rectangular region in the left
panel. Right panel: High power view of rectangular region in central panel.
Arrowheads show the colocalization of tdTomato fluorescence and
Gad65/67 immunoreactivity. (B) Left, Virus injection sites are shown by
dots. Injection site for right panel image is shown by a red dot. Right,
Representative image of HA-like immunoreactivity observed in POA region
of Gad67-Cre mice injected with AAV-DIO-HAhM3Dq to express hM3Dq
fused with HA tag. (C) Activation of POA neurons in Gad67-Cre mice
expressing hM3Dq by CNO. Left panels, upper, representative images of
double-immunostaining with anti-Fos and anti-Gad 65/67 in the POA region
after administration of saline (left) or CNO (right) at 21:00. The brain was
fixed at 23:00. Left panels, lower, high power view of the rectangular
regions shown in upper panels. Arrowheads show the colocalization
of Fos (nuclei) and Gad65/67 (cytoplasm). Right panel, Number of
fos-immunoreactive GABAergic neurons in POA after treatment with saline
or CNO (N = 4 and 4, respectively).
at 23:00, and subjected to double staining with anti-orexin and
anti-Fos antibody. We observed decrease in number of dou-
ble positive cells (45.1 ± 6.5% vs. 27.3 ± 5.3%) (Figure 2D),
although it was unknown whether the inhibition was directly
mediated by POA GABAergic neurons or rather resulted from
increased amount of sleep, because orexin neuronal activity was
shown to correlate with the amount of wakefulness (Estabrooke
et al., 2001).
POA GABAergic NEURONS SEND INNERVATIONS TO REGIONS
IMPLICATED IN THE REGULATION OF SLEEP/WAKEFULNESS STATES
We next examined whether POA GABAergic neurons
directly innervate orexin neurons. We injected AAV-DIO-
hChR2(H134R)-EYFP into the POA of Gad67-Cre mice, because
ChR2 works well as an anterograde tracer (Harris et al., 2012).
Because ChR2-eYFP is distributed in axons and dendrites,
it is difficult to observe cell bodies of neurons that express
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FIGURE 2 | Specific pharmacogenetic stimulation of GABAergic neurons
in the POA increased NREM sleep amount. (A) Total time of wakefulness
(WAKE), NREM sleep and REM sleep for 3 h after CNO (or saline)
administration at 21:00 (upper panels, Saline n = 14, CNO n = 13) and at
13:00 (lower panels, Saline n = 7, CNO n = 7). (B) Episode duration of
WAKE, NREM sleep, and REM sleep for 3 h after CNO (or saline)
administration at 21:00 (upper panels, Saline n = 14, CNO n = 13) and at
13:00 (lower panels, Saline n = 7, CNO n = 7). (C) EEG power density of
WAKE, NREM sleep and REM sleep in 1–2 h time window after the
administration of CNO or saline at 21:00 (Saline n = 14, CNO n = 13). EEG
power density is shown as the mean percentage of total EEG power ±
s.e.m. (D) Representative images of fos expression in orexin neurons, as
shown by double staining of the LHA of Gad67-Cre mice 2 h after injection of
saline (n = 5) or CNO (n = 8) at 21:00. Scale bars, 50µm. Right panel, ratio of
Fos-positive orexin neurons after injections of saline or CNO. Arrowheads
show colocalization of Fos (nuclei) and orexin (cytoplasm).
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ChR2-eYFP, we examined the expression pattern of ChR2-eYFP
mRNA in the POA by double label in situ hybridization to detect
the original cell bodies that expressed ChR2-eYFP mRNA and
Gad67 mRNA (Figure 3A). ChR2-eYFP mRNA-expressing cells
were widely spread within the POA. Almost all these ChR2-eYFP
mRNA-positive neurons also expressed Gad67 mRNA. We
injected the virus into 27 mice, and selected four mice in which
Gad67 mRNA expression was confirmed to be restricted within
the POA.
Following the specific expression of ChR2 in GABAergic neu-
rons in the POA of Gad67-Cre mice, we observed a network
of ChR2-containing axons in the brain by immuostaining the
YFP-positive fibers (Figure 3B, Table 1). We found abundant
ChR2-eYFP-positive fibers in many of known arousal-related
FIGURE 3 | Mapping of projection sites of the POA GABAergic
neurons. (A) Expression of ChR2-eYFP mRNA (blue) and Gad67
mRNA (red) in the POA of Gad67-Cre mice after bilateral injection of
AAV-DIO-hChR2(H134R)-eYFP into the POA. Almost all (>95%, n = 4)
ChR2-eYFP mRNA-positive neurons also expressed Gad67 mRNA.
Arrowheads show co-localization of ChR2-eYFP mRNA and Gad67
mRNA. (B) After injection of AAV-DIO-hChR2(H134R)-eYFP into the
POA of Gad67-Cre mice, the brain was subjected to histological
analysis. Representative images show localization of ChR2-positive
fibers from rostral to caudal in Gad67-Cre mouse brain coronal
sections revealed by immunohistochemical staining using anti-GFP
antiserum. (C) Images of single confocal planes showing
ChR2-positive axonal fibers observed in the LHA, VTA, LC, LDT, PPT,
DR, and TMN. Slices were stained with anti-GFP (green) and
designated antibodies (red), including anti-orexin, anti-TH, anti-ChAT,
anti-TPH and anti-HDC antibodies. Scale bars: 40µm.
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Table 1 | Projection sites of POA GABAergic neurons.
Cell group Relative density
I. FOREBRAIN
A. Isocortex
I ±
II ±
III ±
IV ±
V ±
VI ±
Claustrum ++
Endoperiform nucleus ++
B. Hippocampal formation
1. Entorhinal area +
2. Subculum +
3. CA1 +
4. CA2 +
5. CA3 +
6. Dentate ±
7. Induseum griseum −
C. Amygdala
1. Medial nucleus ++
2. Amygdalohippocampal area −
3. N. lat. Olfactory tract −
4. Anterior amygdaloid area −
5. Central nucleus −
6. Lateral nucleus −
7. Basolateral nucleus +
8. Basomedial nucleus +
9. Intercalated nuclei +
10. Cortical nucleus +
D. Septum
1. Lateral nucleus + + +
Dorsal part + + +
Intermediate part + + +
Ventral part + + +
2. Medial nucleus + + +
3. Bed n. stria terminalis + + +
Rosteromedial resion + + +
Rosterolateral resion + + +
Posterodorsal resion + + +
Posteroventral resion + + +
4.Septofimbrial nucleus + + +
5. Subfornical organ + + +
6. Bed n. anterior commissure + + +
E. Basal ganglia
1. Caudoto putamen −
2. Glabus pallidus −
3. Substantia nigra, Conpact part + + +
4.Substancia nigra, reticular part −
5. Subthalamic mucleus ++
F. Thalamus
1. Medial habenula + + +
2. Lateral habenula ++
(Continued)
Table 1 | Continued
Cell group Relative density
3. Anterior group
Anteroentral n. + + +
Anteromedial n. ++
Anterodorsal n. ++
Interanterolmedial n. −
Interamediodorsal n. +
4. Mediodorsal nucleus
Medial part + + +
Central part + + +
Lateral part −
5. Lateral groupe
Lateral dorsal n. −
Lateral posterior n. −
6. Midline group
Paraventricular n. + + +
Paratenial n. +
Central medial n. + + +
Centrolateral n. −
Rhomboid n. −
N. reuniens −
7. Posterior complex +
8. Medial geniculate n. −
9. Lateral geniculate n. −
10. Intralaminar nuclei −
11. Reticular nucleus −
12. Zona incerta +
13. N.firlds of Forei ±
G. Hypothalamus
1. Periventricular zone + + +
Median preoptic n. + + +
Anteroventral periventricular n. + + +
Preoptic periventricular nucleus + + +
Suprachiasmatic n. + + +
Supraoptic nucleus + + +
Paraventricular n. + + +
Parvicellular part, post + + +
Magnocellular part + + +
Periventricular nucleus + + +
Arcuate nucleus + + +
Posterior periventricular n. ++
2. Medial zone
Medial preoptic area + + +
Medial preoptic n. + + +
Anterior hypothalamic n. + + +
Retrochiasmatic area + + +
Ventromedial n. + + +
Dorsomedial n. + + +
Tuberomammillary n. + + +
Supramammillary n. + + +
Lateral mammillary n. + + +
Medial mammillary n. + + +
3. Lateral zone
(Continued)
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Table 1 | Continued
Cell group Relative density
Lateral preoptic area + + +
Lateral hypothalamic area + + +
Posterior hypothalamic area + + +
II. BRAIN STEM
A. Sensory
1. Visual
Superior colliculus −
Parabigeminal n. −
Pretectal resion
Olivary n. −
N. optic tract −
Anterior n. −
Posterior n. −
Medial pretectal area −
N. posterior commissure −
2. Somatosensory
Mesencephalic n. (5) +
Principal sensory, n. (5) −
Spinal n. −
Gracile n., dorsal −
3. Auditory
Cochlear nuclei
Dorsal −
Ventral −
N. trapezoid body ±
Superior olive +
N. lateral lemniscus −
Inferior colliculus −
Exterminal −
Dorsal −
Central −
N. brachium inf. Coll. −
4. Vestibular −
5. Visceral
N. solitary tract −
Area postrema −
Parabranchial n.
Lateral +
Medial +
B. Motor
1. Eye
Oculomotor(3) +
Edinger-westphal nucleus ++
Trochlear(4) +
Abducens(6) −
2. Jaw
Motor n. (5) −
3. Face
Facial n. (7) ±
4. Pharynx/larynx
(Continued)
Table 1 | Continued
Cell group Relative density
N. ambiguus −
5. Tongue
Hypoglossal. n.(12) −
6. Viscera
Dorsal motor n. (10) +
C. Reticular core (including central gray and raphe)
1. Periaqueductal gray-assoc. w/PAG
Interstitial n. of cajal −
Dorsal tegmental n. −
Laterodorsal teg. N. + + +
Barrington’s n. + + +
Locus coeruleus + + +
2. Raphe
Interfascicular n. + + +
Rostral linear n. + + +
Dorsal raphe + + +
Median raphe + + +
N. raphe pontis + + +
N. raphe magnus + + +
N. raphe pallidus + + +
3. Interpeduncular n.
Rostral subnucleus ±
Apical subnucleus ±
Dorsomedial subnucleus −
Lateral subnucleus ±
Intermediate subnucleus +
Central subnucleus +
4. Reticular formation
Central teg. field +
Peripeduncular n. −
Pedunculopontine n. ++
Cuneiform n. ++
Pontine reticular +
Parvocellular ret. Firld +
Gigantocellular ret. +
Lat. paragigantocellular +
Intermediate ret. field −
Paramedian reticular n. −
D. Pre- and postzerebellar
1. Pontine gray −
2. Tegmental reticular n. −
3. Lateral reticular n. −
4. Red nucleus −
5. N.Roller −
6. Prepositus hypoglossal nucleus −
III. CEREBELLUM
1. Flocculus −
2. Other parts −
We attempt to grade the density of fiber-like structures in the sections into five
categories according to Nambu et al. (1999); dense (+ + +); moderately dense
(++); sparse (+); very sparse (−).
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regions in the hypothalamus and brain stem, including the LHA,
ventral tegmental area (VTA), substantia nigra pars compacta
(SNc), TMN, LC, and LDT (Figure 3B). The projecting fibers
seemed to avoid the main part of the dorsal raphe (DR), and
density of the fibers in the PPT was sparser than other arousal-
related regions, although we found considerable numbers of
YFP-positive fibers in these regions (Figure 3C). Double stain-
ing studies suggested that these fibers made apposition to LC
noradrenergic neurons, PPT cholinergic neurons, DR serotoner-
gic neurons and TMN histaminergic neurons (Figure 3C). When
we infectedAAV-DIO-hChR2(H134R)-EYFP into the POA unilat-
erally, most of (>95%) the axonal projections were found in the
ipsilateral side (not shown).
We found prominent projections to the LHA (Figures 3B,C),
in which orexin neurons are localized. Double staining of LHA
slices with anti-GFP and anti-orexin antibodies showed that
most orexin neurons in the LHA were densely surrounded by
rich ChR2-eYFP fibers (Figure 3C). This suggests that POA
GABAergic neurons send innervations to orexin neurons in
the LHA.
DETECTING SPIKE-MEDIATED GABA RELEASE FROM AXONS OF POA
NEURONS ONTO OREXIN NEURONS
To test if stimulation of these axons modulates activity of
orexin neurons, we performed whole-cell patch-clamp record-
ings from orexin neurons during optical stimulation of ChR2-
eYFP-containing axons. To make identification of orexin neurons
easy, we expressed tdTomato specifically in orexin neurons by
AAV-mediated gene transfer (AAV-horexin-tdTomato). We used
the human prepro-orexin promoter (Sakurai et al., 1999) to
express tdTomato specifically in orexin neurons (Figure 4A).
Immunolabeling confirmed that virtually all (>97%, n = 3)
tdTomato-expressing neurons also contained detectable orexin-
like immunoreactivity, suggesting highly specific expression of
tdTomato in orexin neurons after injection of AAV (Figure 4B),
although there were many orexin neurons that were negative for
tdTomato fluorescence, suggesting incomplete penetrance of the
virus-mediated expression.
To examine the connectivity between POA GABAergic neu-
rons and orexin neurons, we simultaneously injected AAV-DIO-
hChR2(H134R)-EYFP into the POA and AAV-horexin-tdTomato
in the LHA of Gad67-Cre mice. 14 days after the injection, we
prepared acute LHA slices andmade patch clamp recordings from
red fluoresced cell. We then stimulated axons with light emitting
diode (LED) light of 470 nm in a 90-µm diameter window sur-
rounding recorded orexin neurons. When orexin neurons were
recorded under current-clamp with zero holding current, the
light flashes slowed firing rate (Figure 4C). After recording for
several minutes without stimuli, we applied 20-ms light stim-
uli (10Hz). Since a previous study suggested the firing rates of
sleep-active neurons in the POA ranged between about 5 and
20Hz (Takahashi et al., 2009), we tried stimulation frequencies
of 6, 10, and 20Hz, and found that frequencies above 20Hz
evoked strong inhibition, but this lasted a very short time (for
only about 2 s). Because 10Hz stimulation caused strong and
long-lasting inhibition of orexin neurons (data not shown), we
used 10Hz stimulation throughout this study. The inhibition
of orexin neuron firing was completely abolished by a specific
GABAA antagonist, bicuculline (Figure 4C).
Optical stimulation of ChR2-axons located near orexin neu-
rons produced fast inhibitory post-synaptic currents (IPSCs) in
these cells (Figure 4D). Orexin neurons from slices prepared from
mice without ChR2 expression did not show any membrane
responses to the same light flashes (n = 10, data not shown),
confirming that without ChR2, our optical stimulation does not
affect synaptic input to orexin neurons. In ChR2-expressing slices,
the delay between flash onset and post-synaptic response was
3.4 ± 1.3ms (Figure 4E). This short delay suggests that it is
likely that GABAeric fibers extending from the POA directly
inhibit orexin neurons. These observations show that GABAergic
axons originating from POA neurons modulate orexin neurons
via GABAA receptor-mediated synaptic transmission.
DISCUSSION
Extracellular recording studies have demonstrated cells in the
POA that display elevated firing rates during sleep with atten-
uated firing during wakefulness (Findlay and Hayward, 1969;
Kaitin, 1984). The discharge rate of these “sleep-active” neurons
increased several seconds prior to NREM sleep onset as defined
by EEG changes. These observations suggest that the POA plays
an important role in the initiation and maintenance of sleep.
Approximately 80% of sleep-active neurons in the VLPO also
contain the neuropeptide galanin, which is highly colocalized
with GABA in VLPO neurons (Sherin et al., 1998; Gaus et al.,
2002). The number of Fos and GAD-double positive neurons
in both the MnPN and the VLPO was shown to be positively
correlated with the amount of preceding sleep (Gong et al., 2004).
These POA sleep-regulatory neurons were shown to be acti-
vated by adenosine through both direct and indirect actions.
Adenosine caused A1 receptor-mediated suppression of sponta-
neous IPSPs in rat VLPO neurons recorded in vitro (Chamberlin
et al., 2003). Moreover, an adenosine A2A receptor agonist
evoked direct excitatory effects on a subset of rat VLPO neu-
rons (Gallopin et al., 2005). Furthermore, perfusion of an A2A
agonist into the POA in rats promoted sleep (Satoh et al., 1999).
These mechanisms have been thought to play an important role
in homeostatic regulation of sleep through actions of adenosine.
A recent extracellular recording study suggested widespread
distribution of sleep-active neurons within the whole POA
(Takahashi et al., 2009), so it is necessary to genetically target the
cell types being manipulated. In this study, we expressed hM3Dq
or ChR2 broadly in GABAergic neurons in the POA. Firstly, we
confirmed that specific stimulation of POA GABAergic neurons
leads to an increase of NREM time (Figure 2). Sasaki et al. (2011)
reported the same or even more NREM induction by hM4D-
mediated inhibition of orexin neurons. This was unexpected,
because the activation of POA GABA neurons should suppress
more wake-active neurons widely throughout the brain. One pos-
sible reason why the effects were not so strong in this study is
that we activated large numbers of GABAergic neurons in the
POA. It is known that only limited number of GABAergic neu-
rons in the POA would become active during sleep. However,
in this study, larger numbers of the GABAergic neuorns in the
POA, including GABAergic interneurons, might be activated.
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FIGURE 4 | Optogenetic stimulation of POA GABAergic axons rapidly
decreases orexin neuron firing. (A) Strategy of this study. We
simultaneously injected AAV-horexin-tdTomato into the LHA and
AAV-DIO-hChR2(H134R)-eYFP into the POA. (B) Identification of orexin
neurons in the LHA by expression of tdTomato in these neurons after
injection of AAV-horexin-tdTomato. Left: Coronal section at bregma
−2.1mm showing distribution of orexin neurons stained by anti-orexin
antiserum (green). Center: Cells with red fluorescence of tdTomato. Right:
Merged image (C) Typical electrical current-clamp recording of orexin
neuron. Left: Example of changes in firing of orexin neurons induced by
optical stimulation in the absence (top trace) and presence (bottom trace)
of bicuculline (20µM). We observed similar responses in three out of eight
cells. Right: Group data for response and recovery at 10Hz stimulation,
expressed at % change in firing before (B), during (S) and after (R) light
stimulation. (D) Optogenetically induced IPSCs in orexin neurons with and
without bicuculline (20µM). Holding potential was −60mV. Black bar
indicates light stimulus (5ms, 1Hz). Individual responses without
bicuculline are shown in gray, average without bicuculline is in black, and
average with bicuculline is in red. (E) Times after light-on to IPSPs onset
are plotted for individual stimulations.
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Some population of GABAerigic neurons might rather inhibit
sleep-active neurons to counteract direct activation of these cells
by CNO.
We also expressed ChR2-eYFP selectively in GABAergic neu-
rons in the POA of Gad67-Cre mice. This allowed us to trace
axonal fibers of these cells, and perform fast electrical control
of action potential firing of these fibers with light (Petreanu
et al., 2007). Firstly, we examined the pattern of axonal pro-
jections by staining eYFP with an anti-GFP antibody. This
revealed that GABAergic neurons in the POA send projections
to arousal-regulating regions in the brain stem, including the
LC, DR, LDT/PPT, and TMN (Figures 3B,C, Table 1). Double
immunofluorescence study further suggested that these axonal
fibers make appositions to orexin neurons in the LHA as well
as other arousal-related neurons including TH-positive, nora-
drenergic cells in the LC, serotonergic cells in the raphe nuclei,
cholinergic cells in the LDT, and histaminergic cells in the TMN
(Figure 3C).
We next examined the effect of optogenetic stimulation
of ChR2-positive fibers around orexin neurons in the LHA
(Figure 4). In the stimulation paradigms used here, blockade of
GABAA receptors completely abolished the post-synaptic effect
of GABAergic axon stimulation, suggesting that release of other
transmitters, such as galanin, was not sufficient to alter orexin
neuron firing.
Previous studies as well as our present findings suggest that
POAGABAergic neurons send rich innervations tomultiple brain
regions, including monoaminergic/cholinergic nuclei in the brain
stem, which fire at a rapid rate during wakefulness, slow down
during NREM sleep, and cease firing during REM sleep, and
are implicated in maintenance of wakefulness (Figure 3B). This
means it is difficult to speculate on the relative contribution of
the inhibitory action on orexin neuronal activity in increasing
NREM sleep time. However, because specific pharmacogenetic or
optogenetic inhibition of orexin neurons was shown to increase
NREM sleep (Sasaki et al., 2011; Tsunematsu et al., 2011), it
is possible to speculate that POA GABAergic neuron-mediated
NREM sleep promotion might be at least partly through the
inhibition of orexin neurons. Further studies, including optoge-
netic/pharmacogenetic activation/inhibition of POA GABAergic
neurons in vivo in orexin-deficient animals, will be required to
address this.
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